Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
39.14
-0.25 (-0.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AMPH stock have an average target of 60.33, with a low estimate of 55 and a high estimate of 66. The average target predicts an increase of 54.14% from the current stock price of 39.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AMPH stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +40.52% | Nov 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $71 → $66 | Buy | Maintains | $71 → $66 | +68.63% | Aug 8, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $71 | Buy | Reiterates | $71 | +81.40% | Jun 27, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 22, 2024 |
Financial Forecast
Revenue This Year
753.02M
from 644.40M
Increased by 16.86%
Revenue Next Year
828.86M
from 753.02M
Increased by 10.07%
EPS This Year
3.98
from 2.60
Increased by 53.00%
EPS Next Year
4.41
from 3.98
Increased by 10.85%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 779.4M | 873.8M | 1.0B | |||
| Avg | 753.0M | 828.9M | 899.5M | |||
| Low | 718.8M | 776.3M | 816.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 20.9% | 16.0% | 24.1% | |||
| Avg | 16.9% | 10.1% | 8.5% | |||
| Low | 11.6% | 3.1% | -1.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.39 | 4.88 | 6.05 | |||
| Avg | 3.98 | 4.41 | 5.05 | |||
| Low | 3.73 | 4.08 | 4.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 68.8% | 22.7% | 37.2% | |||
| Avg | 53.0% | 10.9% | 14.4% | |||
| Low | 43.6% | 2.6% | -3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.